ATE535544T1 - Verfahren zur verhinderung von polymeren des humanen serumalbumins - Google Patents

Verfahren zur verhinderung von polymeren des humanen serumalbumins

Info

Publication number
ATE535544T1
ATE535544T1 AT01978882T AT01978882T ATE535544T1 AT E535544 T1 ATE535544 T1 AT E535544T1 AT 01978882 T AT01978882 T AT 01978882T AT 01978882 T AT01978882 T AT 01978882T AT E535544 T1 ATE535544 T1 AT E535544T1
Authority
AT
Austria
Prior art keywords
human serum
preventing human
aluminum polymers
serum aluminum
serum albumin
Prior art date
Application number
AT01978882T
Other languages
English (en)
Inventor
Satoshi Adachi
Hiroshi Mizokami
Yoshitaka Tajima
Yoshinobu Miyatsu
Toshinobu Nouchi
Yoshitaka Ushio
Original Assignee
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeut Res Inst filed Critical Chemo Sero Therapeut Res Inst
Application granted granted Critical
Publication of ATE535544T1 publication Critical patent/ATE535544T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01978882T 2000-10-24 2001-10-24 Verfahren zur verhinderung von polymeren des humanen serumalbumins ATE535544T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000324029A JP4798832B2 (ja) 2000-10-24 2000-10-24 ヒト血清アルブミン多量体の除去方法
PCT/JP2001/009335 WO2002034786A1 (en) 2000-10-24 2001-10-24 Method of eliminating human serum albumin polymers

Publications (1)

Publication Number Publication Date
ATE535544T1 true ATE535544T1 (de) 2011-12-15

Family

ID=18801620

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01978882T ATE535544T1 (de) 2000-10-24 2001-10-24 Verfahren zur verhinderung von polymeren des humanen serumalbumins

Country Status (11)

Country Link
US (1) US7001885B2 (de)
EP (1) EP1329461B8 (de)
JP (1) JP4798832B2 (de)
KR (1) KR100847883B1 (de)
CN (1) CN1406245B (de)
AT (1) ATE535544T1 (de)
AU (1) AU783871B2 (de)
CA (1) CA2395589C (de)
DK (1) DK1329461T3 (de)
ES (1) ES2373035T3 (de)
WO (1) WO2002034786A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
CN1275981C (zh) * 2000-10-24 2006-09-20 财团法人化学及血清疗法研究所 人血清白蛋白多聚体的单体化方法
SE526227C2 (sv) * 2002-05-15 2005-08-02 North China Pharmaceutical Group Metod för rening av rekombinant humant serumalbumin
JPWO2005004902A1 (ja) * 2003-07-10 2006-08-24 ニプロ株式会社 プラスチック容器入り組換えヒト血清アルブミン製剤
FR2866890B1 (fr) * 2004-02-27 2008-04-04 Lab Francais Du Fractionnement Procede de purification d'albumine comprenant une etape de nanofiltration, solution et composition a usage therapeutique la contenant
CN102190722B (zh) * 2010-03-16 2014-03-26 上海欣瑞特生物医药技术有限公司 一种纯化重组人血白蛋白的方法
WO2013115583A1 (ko) * 2012-01-31 2013-08-08 이화여자대학교 산학협력단 일산화질소에 의해 형성되는 알부민 다량체 및 알부민 구조변형체
US20140186447A1 (en) * 2012-12-28 2014-07-03 Abraxis Bioscience, Llc Nanoparticle compositions of albumin and paclitaxel
US10705070B1 (en) 2015-03-05 2020-07-07 Abraxis Bioscience, Llc Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug
US10527604B1 (en) 2015-03-05 2020-01-07 Abraxis Bioscience, Llc Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel
EP3429345B1 (de) 2016-10-04 2019-09-11 Albumedix Ltd. Verwendungen von rekombinantem, von hefe abgeleitetem serumalbumin
CN107216383A (zh) * 2017-07-13 2017-09-29 同路生物制药有限公司 一种人血白蛋白的制备方法及该人血白蛋白
IL292439B2 (en) 2019-10-28 2026-05-01 Abraxis Bioscience Llc Pharmaceutical preparations of albumin and rapamycin
EP4069200A1 (de) 2019-12-04 2022-10-12 Albumedix Ltd Verfahren und damit hergestellte zusammensetzungen
US12629445B2 (en) 2020-03-20 2026-05-19 Bard Peripheral Vascular, Inc. Reactive hydrogel forming formulations and related methods, including methods of preparation
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
WO2022146917A1 (en) 2020-12-28 2022-07-07 Davol Inc. Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169829A (en) * 1972-07-05 1979-10-02 Institut Merieux Process for the preparation of purified albumin and albumin obtained by said process
IL66614A (en) 1981-08-28 1985-09-29 Genentech Inc Method of constructing a dna sequence encoding a polypeptide,microbial production of human serum albumin,and pharmaceutical compositions comprising it
US4705848A (en) * 1986-06-02 1987-11-10 International Minerals & Chemical Corp. Isolation of bioactive, monomeric growth hormone
IL88326A (en) 1987-11-18 1993-03-15 Gist Brocades Nv Purification of serum albumin
JP2926722B2 (ja) 1988-10-20 1999-07-28 吉富製薬株式会社 アルブミン製剤及びその製造方法
JP3554796B2 (ja) * 1988-10-31 2004-08-18 三菱ウェルファーマ株式会社 アルブミン製剤及びその製造方法
JPH0768137B2 (ja) * 1989-06-15 1995-07-26 株式会社ミドリ十字 アルブミン製剤及びその製法
JPH0671434B2 (ja) 1989-09-18 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法
JPH04234326A (ja) * 1990-12-27 1992-08-24 Green Cross Corp:The アルブミン製剤及びその製法
JPH0671434A (ja) 1991-05-30 1994-03-15 Tadahiro Omi クリーンチャンバーの溶接方法
JPH07102148B2 (ja) * 1992-05-20 1995-11-08 株式会社ミドリ十字 遺伝子操作により得られるヒト血清アルブミンの製造方法、およびそれにより得られるヒト血清アルブミン含有組成物
US5521287A (en) * 1992-05-20 1996-05-28 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
JP3508149B2 (ja) * 1993-02-25 2004-03-22 三菱ウェルファーマ株式会社 ヒト血清アルブミンおよびその製造方法
US5440018A (en) * 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5728553A (en) 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
JPH07126182A (ja) 1993-10-27 1995-05-16 Green Cross Corp:The 組換えヒト血清アルブミン製剤の滅菌方法
CA2138349A1 (en) * 1993-12-17 1995-06-18 Welfide Corporation Method for decoloring human serum albumin
JP3702474B2 (ja) * 1994-06-01 2005-10-05 三菱ウェルファーマ株式会社 血清アルブミン製剤の製造方法
JP3840674B2 (ja) 1994-08-31 2006-11-01 三菱ウェルファーマ株式会社 遺伝子操作に由来するヒト血清アルブミンの精製方法
ES2228052T3 (es) * 1998-06-01 2005-04-01 Genentech, Inc. Separacion demonomeros de anticuerpos de sus multimeros utilizando cromatografia de intercambio de iones.

Also Published As

Publication number Publication date
JP4798832B2 (ja) 2011-10-19
DK1329461T3 (da) 2012-01-30
CA2395589C (en) 2012-08-28
CN1406245B (zh) 2010-05-26
AU783871B2 (en) 2005-12-15
EP1329461B1 (de) 2011-11-30
US7001885B2 (en) 2006-02-21
AU1093502A (en) 2002-05-06
KR20020065608A (ko) 2002-08-13
EP1329461B8 (de) 2012-03-14
EP1329461A1 (de) 2003-07-23
CN1406245A (zh) 2003-03-26
WO2002034786A1 (en) 2002-05-02
KR100847883B1 (ko) 2008-07-23
EP1329461A4 (de) 2004-12-01
CA2395589A1 (en) 2002-05-02
US20020183492A1 (en) 2002-12-05
ES2373035T3 (es) 2012-01-30
JP2002128795A (ja) 2002-05-09

Similar Documents

Publication Publication Date Title
DK1329461T3 (da) Fremgangsmåde til fjernelse af humane serum-albumin-polymerer
DE69711034D1 (de) Wässrige fluorpolymerlösungen zur behandlung von harten oberflächen
DE69435266D1 (de) Methode zur Detektion von Luftblasen
DE69628564D1 (de) Verfahren zur reinigung von viren mit chromatographie
DE69735295D1 (de) Verfahren zur Aufkonzentrierung von Antikörperlösungen
BR9407047A (pt) Processo para separaçao de uma proteina de uma soluçao aquosa de proteinas
DE69124595D1 (de) Verfahren zur Durchflusszytometrie-Unterscheidung der Erythroblasten von anderen Zellen
EP1450816A4 (de) Verfahren zur behandlung von störungen im zusammenhang mit erhöhter cholesterinkonzentration
ATE96167T1 (de) Verfahren zur kristallisation von enzymen.
DE69005959D1 (de) Verfahren zur Reinigung von menschlichem Serum-Albumin.
DE69623191D1 (de) Verfahren zur Konzentration von saurem Phospholipid
DE60021590D1 (de) Verwendung von baclofen zur behandlung von alkoholismus
SE9404141D0 (sv) New buffer system for electrophoresis
ATE126531T1 (de) Verfahren zur gewinnung von natürlich hergestelltem chymosin.
DE69415837D1 (de) Verfahren zur Verminderung des freien Aldehydgehaltes von N-Alkylolamidmonomeren
DE60104832D1 (de) Behandlungsanlage zur flüssigkeitsbearbeitung von kontaktlinsen
DE60234811D1 (de) Verfahren und zusammensetzungen zur extraktion von proteinen aus zellen
ATE149514T1 (de) Verfahren zur reaktivierung von denaturiertem protein
DE3874667D1 (de) Verfahren zur reinigung von methacrylsaeure.
DE59105092D1 (de) Verfahren zur extraktiven Trennung von L-Phosphinothricin und L-Glutaminsäure in wässriger Lösung.
DE69618536D1 (de) Verfahren zur Inaktivierung von Viren in Proteinen
DE69433607D1 (de) Methoden zur kennzeichnung von komplexen filtrationsmitteln
DE3884277D1 (de) Verwendung von Salzen von Sulfonamidocarbonsäuren als Korrosionsinhibitoren in wässrigen Systemen.
DE50113517D1 (de) Verfahren zur prognose des kumulativen überlebens von patienten
DE3870812D1 (de) Verfahren zur verringerung des wassergehaltes in piezoelektrischen galliumphosphat-kristallelementen.